DCTH - Delcath Systems Quarterly EPS earnings growth

Delcath Corp - graphic logo of issuer DCTH

Delcath Systems, Inc. (DCTH) relies on the supply of unique liver chemotherapy equipment, which ensures steady demand for consumables. A team of oncology experts is executing a mission to save lives through innovation. Analyzing this chart on GURU.Markets, we note that the quarterly EPS growth rate depends on the adoption pace of the system for melanoma, with the value remaining at 720.80.

delcath.com (DCTH) - Year-over-year earnings per share growth for the last 12 months from 07/04/2022 to 11/12/2026

Financial and market metric breakdowns for Delcath Corp (DCTH)

- market value and analyst target forecast:
Price Chart Delcath Systems|DCTH - Fair Value Consensus
- market capitalization statistics:
Market Capitalization Delcath|DCTH - Total Enterprise Value
- balance sheet net asset value indicators:
Book Value per Share Delcath Systems|DCTH - Accounting Capitalization|Market Capitalization to Book Value Ratio delcath.com|DCTH - Company Assets
- company liabilities and liquidity data:
Debt to Equity Delcath Systems, Inc.|DCTH - Long-Term Debt to Equity|Short-Term Debt to Capital Delcath Systems, Inc.|DCTH - Company Total Debt|Debts to Book Capitalization Delcath|DCTH - Company Long-Term Debts|Company Current Liabilities Delcath Systems|Quick Ratio delcath.com
- earnings and valuation multiples indicators:
DCTH - Final Profit|Future Profit Delcath Systems, Inc.|DCTH - Company Value to Net Income|Future Price to Earnings Delcath|DCTH - Growth-Adjusted Market Cap to Net Income|Enterprise Value to EBITDA Ratio Delcath|DCTH - Profit before interest, taxes and amortization|Earnings per share for the last twelve months Delcath Systems|DCTH - Net earnings per share for the last four quarters|Year-over-year net earnings per share growth for the last 12 months delcath.com|DCTH - Net earnings per one share growth for the current year|Earnings growth forecast for next year Delcath Systems, Inc.
Basic company analysis:Delcath Systems - DCTH
Manufactured product of Delcath Corp

This indicator measures the dynamics of net earnings per share, excluding random market fluctuations to identify the real profitability trend. Positive momentum indicates effective capital management and growth in operating profit. By analyzing the quarterly percentage increase in earnings per share, an investor assesses business scalability. For Delcath Systems, Inc. (DCTH), this metric reflects the successful implementation of Hepzato and the expansion of the clinic network. Growth in this metric confirms the commercial efficiency of targeted chemotherapy.

Competitor analysis

BeiGene (ONC) - Year-over-year earnings per share growth for the last twelve months|Halozyme Therapeutics, Inc. - Year-over-year earnings per one share growth for the last 12 months|RVMD (RevMed) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Ascentage Pharma Corp AAPG|Quarterly EPS earnings growth CGON|urogen.com - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth BCAX (Bicara Therapeutics)|Personalis Inc (PSNL) - Earnings per share growth in annualized terms for the last twelve months|ERAS - Year-over-year earnings per share growth for the last twelve months|YMAB: Year-over-year earnings per share growth for the last twelve months|AURA: Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Candel Therapeutics, Inc.|ARAY (Accuray) - Quarterly EPS earnings growth|Quarterly EPS earnings growth SELLAS Life Sciences Group Inc.|Year-over-year net earnings per share growth for the last 12 months ACTU (Actuate Therapeutics, Inc)|Year-over-year earnings per share growth rate for the last twelve months CTOR|Quarterly EPS earnings growth HURA (TuHURA Biosciences)|Year-over-year earnings per one share growth for the last 12 months TARA|FATE: Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months WHWK (Aadi Bioscience Inc)|tscan.com (TCRX) - Year-over-year earnings per share growth for the last twelve months|CSBR - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months XBIT|Earnings per share growth in annualized terms for the last twelve months CEL-SCI Corp CVM|Year-over-year earnings per share growth for the last twelve months OS Therapies (OSTX)|Year-over-year net earnings per share change for the last twelve months Radiopharm Theranostics Ltd|Artiva Biotherapeutics - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months ANL (Adlai Nortye Ltd)|Veru Inc. - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months tempesttx.com|xiliotx.com (XLO) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months Renovaro|Year-over-year earnings per share growth for the last twelve months Mural Oncology PLC|Kairos Pharma Inc (KAPA) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months OKUR (OnKure Therapeutics Inc)|GDTC (w2.cytomed.sg) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth CRIS (Curis)|Year-over-year net earnings per share change for the last twelve months Apollomics Inc. (APLM)|THAR - Year-over-year earnings per share growth for the last twelve months|ADVB (Advanced Biomed Inc) - Year-over-year earnings per share growth for the last 12 months|GNPX: Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Calidi Biotherapeutics, Inc.|Year-over-year net earnings per share growth for the last 12 months SBFM|Xenetic Bio (XBIO) - Year-over-year net earnings per share change for the last twelve months|Quarterly EPS earnings growth SLRX|Kitov Pharma - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth AONC (American Oncology Network, Inc.)|BGNE - Year-over-year net earnings per share growth for the last 12 months|CKPT: Year-over-year net earnings per share growth for the last 12 months|Elevation Oncology Inc. - Year-over-year earnings per share growth rate for the last twelve months|ICAD: Quarterly EPS earnings growth|Ikena Oncology - Year-over-year earnings per one share growth for the last 12 months|NTBL (Notable Labs, Ltd.) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Viracta (VIRX)|Quarterly EPS earnings growth MOR|Quarterly EPS earnings growth NAYA Biosciences Inc (NAYA)|Year-over-year earnings per share growth for the last twelve months Ascentage Pharma Group Ltd AAPGV